Clinical Research Facility

Mason City, Iowa 50401

Use our guide to learn which trials are right for you!

We've found
1 trials
at this facility
Breast Cancer Clinical Trial
Olaparib as Adjuvant Treatment in Patients With Germline BRCA Mutated High Risk HER2 Negative Primary Breast Cancer
Status: Enrolling, Phase III
Updated: 12/31/1969
Clinical Research Facility
mi
from
Mason City, IA
Click here to add this to my saved trials